Lung Cancer Surgery Equipment Market Report 2026

Lung Cancer Surgery Equipment Market Overview

• Lung Cancer Surgery Equipment market size has reached to $3.73 billion in 2025 • Expected to grow to $5.1 billion in 2030 at a compound annual growth rate (CAGR) of 6.4% • Growth Driver: Increasing Lung Cancer Prevalence Driving Market Growth Through Advanced Surgical Solutions • Market Trend: Advancements In Robotically Assisted Bronchoscopy For Enhanced Lung Cancer Diagnosis And Treatment • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Lung Cancer Surgery Equipment Market?

Lung cancer surgery equipment refers to the specialized medical tools and devices used during surgical procedures to diagnose, treat, and monitor lung cancer. These include surgical instruments, imaging systems, biopsy tools, electrosurgical devices, access devices, and patient monitoring equipment designed to assist in removing tumors, minimizing complications, and supporting recovery. The main types of lung cancer surgery equipment are surgical instruments, access devices, imaging equipment, electrosurgical devices, biopsy tools, and patient monitoring systems. Surgical instruments are specialized tools used by surgeons during procedures to cut, clamp, hold, or suture tissues. Common types of lung cancer surgeries include lobectomy, pneumonectomy, wedge resection, video-assisted thoracoscopic surgery (VATS), and robotic-assisted surgery. These procedures serve various purposes such as diagnosis, treatment, and aftercare or rehabilitation. These are used for various end users such as hospitals, surgical clinics, ambulatory surgical centers, and research or academic institutions.

What Is The Lung Cancer Surgery Equipment Market Growth Forecast?

The lung cancer surgery equipment market size is expected to see strong growth in the next few years. It will grow to $5.1 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to development of robotic-assisted and minimally invasive surgical tools, integration of ai-enabled imaging and monitoring systems, growing investment in research and academic institutes, rising adoption of enhanced recovery after surgery (ERAS) protocols, expansion of specialized lung cancer treatment centers. Major trends in the forecast period include increasing adoption of minimally invasive lung surgeries, rising demand for advanced imaging and diagnostic equipment, integration of patient monitoring systems with surgical devices, growing focus on postoperative rehabilitation and aftercare, expansion of robotic-assisted thoracic surgery.

Global Lung Cancer Surgery Equipment Market Segmentation

1) By Product Type: Surgical Instruments, Access Devices, Imaging Equipment, Electrosurgical Devices, Biopsy Devices, Patient Monitoring Equipment 2) By Surgery Type: Lobectomy Surgery, Pneumonectomy Surgery, Wedge Resection, Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery 3) By Application: Diagnosis, Treatment, Aftercare And Rehabilitation 4) By End User: Hospitals, Surgical Clinics, Ambulatory Surgical Centers, Research And Academic Institutes Subsegments: 1) By Surgical Instruments: Scalpels, Forceps, Retractors, Scissors, Sutures 2) By Access Devices: Trocars, Catheters, Guidewires, Introducers 3) By Imaging Equipment: CT Scanners, MRI Machines, PET Scanners, X-Ray Systems, Ultrasound Devices 4) By Electrosurgical Devices: Electrosurgical Generators, Electrosurgical Probes, Electrosurgical Electrodes, Smoke Evacuation Systems 5) By Biopsy Devices: Needle Biopsy Devices, Core Biopsy Devices, Vacuum-Assisted Biopsy Devices, Endoscopic Biopsy Devices 6) By Patient Monitoring Equipment: Pulse Oximeters, ECG Monitors, Respiratory Monitors, Blood Pressure Monitors, Temperature Monitors

What Is The Driver Of The Lung Cancer Surgery Equipment Market?

The growing prevalence of lung cancer is expected to propel the growth of the lung cancer surgery equipment market going forward. Lung cancer is a disease where abnormal cells grow uncontrollably in the lungs, usually due to smoking or harmful environmental exposure. Lung cancer cases are rising largely due to greater exposure to risk factors such as tobacco smoke, air pollution, and occupational carcinogens combined with an aging population. Lung cancer surgery equipment is used to diagnose, remove cancerous tissue, and support post-operative care through precise surgical intervention and patient monitoring. For instance, in February 2025, according to the Cancer Council, an Australia-based non-profit organization, in 2024, an estimated 15,122 individuals were diagnosed with lung cancer in Australia, with the average age at diagnosis being 72. Lung cancer ranks as the fifth most commonly diagnosed cancer in the country, and approximately one in 20 Australians is expected to be diagnosed with it by the age of 85. Therefore, the growing prevalence of lung cancer is driving the growth of the lung cancer surgery equipment industry.

Key Players In The Global Lung Cancer Surgery Equipment Market

Major companies operating in the lung cancer surgery equipment market are Johnson & Johnson, Medtronic plc, Siemens Healthcare AG, Fujifilm Limited, GE Healthcare Technologies Inc, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, KARL STORZ GmbH & Co KG, Integra LifeSciences Corporation, Richard Wolf GmbH, Angiodynamics Inc, B Braun Melsungen AG, Sontec Instruments Inc, Novadaq Technologies Inc, Stryker Corporation, CONMED Corporation, Smith & Nephew plc, Ambu A S

Global Lung Cancer Surgery Equipment Market Trends and Insights

Major companies operating in the lung cancer surgery equipment market are focusing on developing devices for robotically assisted bronchoscopy to enhance the precision and safety of tumor localization and biopsy, improve access to hard-to-reach lung nodules, and support early and accurate diagnosis of lung cancer. Robotically assisted bronchoscopy is an advanced medical procedure that uses robotic technology to guide a bronchoscope a thin, flexible tube into the lungs with greater precision and control than traditional manual techniques. For example, in March 2025, Johnson and Johnson, a US-based pharmaceutical company announced that its MONARCH QUEST system, an advanced robotic-assisted bronchoscopy technology, has received U.S. FDA 510(k) clearance. This system represents the latest evolution of the MONARCH Platform, which is designed to improve the diagnosis of lung cancer through minimally invasive procedures. The system interfaces with the GE HealthCare OEC 3D mobile CBCT Imaging System, allowing for real-time, intraprocedural 3D imaging. This integration improves the precision of targeting lung nodules, especially those located in hard-to-reach areas of the lung.

What Are Latest Mergers And Acquisitions In The Lung Cancer Surgery Equipment Market?

In August 2024, Karl Storz SE & Co. KG, a Germany-based medical technology company, acquired Asensus Surgical Inc. for an undisclosed amount. With this acquisition, Karl Storz aims to expand its presence in the surgical robotics market and enhance its portfolio with Asensus Surgical’s advanced digital and robotic-assisted surgical technologies. Asensus Surgical Inc. is a US-based medical technology company that specializes in manufacturing surgical robots and digital solutions for various surgeries including lung cancer surgery.

Regional Outlook

North America was the largest region in the lung cancer surgery equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Lung Cancer Surgery Equipment Market?

The lung cancer surgery equipment market consists of sales of staplers, forceps, retractors, monopolar and bipolar electrosurgical generators, ultrasonic scalpels, and pulmonary needles. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.